Browse Tag

muscle building

Hungarian Astronaut Builds Super-Muscles with Futuristic EMSCULPT NEO Device

Hungarian Astronaut Builds Super-Muscles with Futuristic EMSCULPT NEO Device

Inside the Space-Ready Workout Astronauts face rapid muscle and bone loss in zero gravity, so Hungary’s new space traveler Kapu built an astronaut-specific fitness program. As BTL’s press release explains, EMSCULPT NEO was added to Kapu’s intensive training to counteract the muscle atrophy of orbit prnewswire.com. “Studies show astronauts lose up to 30% of muscle mass in orbit,” notes Dr. Nóra Sydó of Budapest’s Semmelweis University, who led Kapu’s training prnewswire.com. Dr. Sydó – also doctor to Hungary’s Olympic swim team – reports that with EMSCULPT NEO, medical tests showed “muscle hypertrophy, improved body composition and increased cardiopulmonary fitness” beyond
Scholar Rock (SRRK) Just Hit a Regulatory Speed Bump—But the Long‑Term Muscle‑Building Story Still Has Legs

Scholar Rock (SRRK) Just Hit a Regulatory Speed Bump—But the Long‑Term Muscle‑Building Story Still Has Legs

Key facts (as of September 26, 2025) What happened this week (Sept. 23–26) Company snapshot & pipeline Scholar Rock is a late‑stage biotech developing apitegromab, a selective antibody that blocks latent myostatin activation to build/maintain skeletal muscle. Pipeline also includes SRK‑181 (anti‑latent TGF‑β1, oncology; Phase 1) and SRK‑439 (next‑gen anti‑latent myostatin; IND planned for 2H25).  Scholar Rock+1 The SMA evidence base: apitegromab’s pivotal data The obesity tie‑in: preserving muscle on GLP‑1s What the CRL really means Expert view: “[We] expect the issue to be resolved in under three months,” said BMO’s Evan Seigerman, framing the CRL as a timetable hiccup rather than a thesis break.  Reuters Financial position & runway Street consensus, targets
26 September 2025
Go toTop